Assessment of quality of life in patients after surgical and transcatheter aortic valve replacement
- 23 January 2016
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 88 (3) , E80-E88
Abstract
Objectives: Transcatheter aortic valve implantation (TAVI) and minimally invasive aortic valve replacement (mini‐thoracotomy, mini‐sternotomy, MIAVR) have become an appealing alternative to conventional surgical (SAVR) treatment of severe aortic stenosis (AS) in high‐risk patients.Background: Aim of the study was to evaluate the quality of life (QoL) in patients with AS and treated with transfemoral TAVI, SAVR, mini‐thoracotomy and mini‐sternotomy.Methods: One hundred and seventy‐three patients with symptomatic AS were enrolled in 2011–2013. TAVI group consisted of 39 patients (22.5%), mini‐sternotomy was performed in 44 patients (25.5%), mini‐thoracotomy in 50 (29%), and AVR in 40 patients (23%). QoL was assessed perioperatively, 12 and 24 months after aortic valve replacement (AVR) by Minnesota Living with Heart Failure Questionnaire (MLHFQ) and EQ‐5D‐3L.Results: Median follow‐up was 583.5 (IQR: 298–736) days. Improvement of health status after procedure in comparison with pre‐operative period was significantly more often reported after TAVI in perioperative period (90.3%;P = 0.004) and 12 months after procedure (100%,P = 0.02). Global MLHFQ, physical and emotional dimension score at 30‐day from AVR presented significant improvement after TAVI in comparison with surgical methods (respectively: 8.3(±8.6),P = 0.003; 4.1(±5.9),P = 0.01; 1.5(±2.6),P = 0.005). Total MLHFQ score was significantly lower (better outcome) in TAVI patients 1 year after procedure (4.8(±6.8),P = 0.004), no differences in somatic and emotional component were found. No differences were found in MLHFQ score 24 months after AVR. Data from EQ‐D5‐3L questionnaire demonstrated significant improvement of QoL at 30‐day follow‐up after TAVI in comparison with surgical methods (1.2(±1.7),P = 0.0008).Conclusions: TAVI improves QoL in perioperative and 12 months observation in comparison with mini‐thoracotomy, mini‐sternotomy and SAVR. Improvement in QoL was obtained in both generic and disease specific questionnaires.Keywords
This publication has 19 references indexed in Scilit:
- Evolution of Transcatheter Aortic Valve ReplacementCirculation Research, 2014
- Clinical outcome and quality of life in octogenarians following transcatheter aortic valve implantation (TAVI) for symptomatic aortic stenosisInternational Journal of Cardiology, 2013
- Cirugía mínimamente invasiva para el recambio valvular aórtico. Una técnica segura y útil más allá de lo estéticoRevista Espanola de Cardiologia, 2013
- Guidelines on the management of valvular heart disease (version 2012)European Heart Journal, 2012
- Improvement of physical and mental health after transfemoral transcatheter aortic valve implantationEuroIntervention, 2012
- Quality of life improvement is maintained up to two years after transcatheter aortic valve implantation in high-risk surgical candidatesEuroIntervention, 2012
- Long-term quality of life improvement after transcatheter aortic valve implantationAmerican Heart Journal, 2011
- EuroQol: the current state of playHealth Policy, 1996
- Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placeboThe American Journal of Cardiology, 1993
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990